Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is AT&T Stock a Buy Now?


AT (NYSE: T) has frustrated investors for years. Costly missteps, a massive debt burden, and a dividend cut after years of annual increases progressively soured investors, so much so that it reversed 30 years of gains!

After such a track record, investors may understandably struggle to believe in this stock again. Nonetheless, with a robust 5G market and a low valuation, it could be time for investors to turn bullish.

Despite its challenges, the company's situation has continued to improve since spinning off DirecTV, and the media business which now is part of Warner Bros. Discovery. The latter spinoff led to a cash infusion of more than $40 billion. That allowed AT to reduce its debt dramatically, though, AT over $143 billion, its total debt level remains a heavy burden.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,062 €
6,03 %
Ein erheblicher Kursanstieg bei Allergy Therapeutics PLC heute, um 6,03 %.

Like: 0
T
Teilen

Kommentare